CASM - CAS Medical Systems, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.9900
+0.0100 (+0.51%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.9800
Open1.9900
Bid1.7500 x 1300
Ask2.5000 x 1000
Day's Range1.9723 - 2.0000
52 Week Range0.5900 - 2.0600
Volume79,151
Avg. Volume158,387
Market Cap55.033M
Beta-0.12
PE Ratio (TTM)N/A
EPS (TTM)-0.1290
Earnings DateAug 6, 2018 - Aug 10, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Trade prices are not sourced from all markets
  • ACCESSWIRElast month

    Wired News - Halyard Health to Buy CoolSystems; Marketed as Game Ready(R)

    LONDON, UK / ACCESSWIRE / June 7, 2018 / If you want access to our free research report on Halyard Health, Inc. (NYSE: HYH), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HYH as the Company's latest news hit the wire. On June 05, 2018, the Company announced that it has inked a deal to acquire CoolSystems, Inc., marketed as Game Ready®, a market-leading provider of cold therapy and compression therapy systems for a total consideration of $65 million in cash. Active-Investors.com is currently working on the research report for CAS Medical Systems, Inc. (NASDAQ: CASM), which also belongs to the Healthcare sector as the Company Halyard Health.

  • GlobeNewswire2 months ago

    CASMED to Present at the 8th Annual LD Micro Invitational Conference on June 5

    BRANFORD, Conn., May 29, 2018-- CAS Medical Systems, Inc., a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will ...

  • Zacks Small Cap Research2 months ago

    CASM: Q1: FORE-SIGHT Revenue Jumps 20% in Q1. Sensors Sales Accelerating. Moving PT to $4.00/share

    CAS Medical (CASM) reported financial results for Q1 2018. It was an extraordinarily strong showing across their FORE-SIGHT franchise with sensors revenue in both the U.S. and international markets jumping double-digits yoy, pushing total sensors sales almost 10% higher than their prior record (in Q4 ’17). Meanwhile, monitor shipments continue to trend higher - 72 shipped in the U.S., which is the second highest level on-record (80 shipped in Q4 ’17) and 39 OUS, which is the highest since Q4 ’16.

  • GlobeNewswire2 months ago

    FDA Clears CASMED’s FORE-SIGHT Tissue Oximetry OEM Module

    CAS Medical Systems, Inc. (CASM) (CASMED), a leader in medical products for non-invasive patient monitoring of tissue oxygenation, announces receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its FORE-SIGHT® Tissue Oximetry OEM Module, an original equipment manufacturer (OEM) version of its next-generation FORE-SIGHT ELITE® Tissue Oximeter. The OEM Module permits the highly accurate tissue oximetry values derived by CASMED’s FORE-SIGHT technology to be displayed on a monitor manufactured by a third party, rather than requiring a standalone FORE-SIGHT monitor.  The OEM Module includes a cable incorporating FORE-SIGHT technology that is connected to FORE-SIGHT disposable sensors placed on the patient’s forehead.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CASM earnings conference call or presentation 10-May-18 2:00pm GMT

    Q1 2018 CAS Medical Systems Inc Earnings Call

  • GlobeNewswire2 months ago

    CASMED Reports First-Quarter 2018 Financial Results

    FORE-SIGHT sales increase 22%; U.S. Company raises 2018 U.S. and international FORE-SIGHT sales guidance. Conference Call Begins at 10:00 a.m. Eastern Time Today.

  • GlobeNewswire2 months ago

    CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10

    BRANFORD, Conn., May 03, 2018-- CAS Medical Systems, Inc., a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the first quarter of 2018 ...

  • Zacks Small Cap Research4 months ago

    CASM: Q4 2017 Financial Results: Record Revenue, Lowest Op Loss. Momentum Expected to Continue

    CAS Medical (CASM) reported financial results for Q4 2017, which saw revenue well ahead of our pre-preliminary announcement numbers (CASM pre-announced Q4 in early January). Strength in the U.S. market, which has been attributed to a combination of catalysts, more than offset a double-digit decline in international sales and pushed total FORE-SIGHT revenue to an all-time high. Indications, which includes 2018 guidance of low-teens percentage increase in U.S. FORE-SIGHT revenue, are that this momentum will continue, and potentially accelerate.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of CASM earnings conference call or presentation 14-Mar-18 2:00pm GMT

    Q4 2017 CAS Medical Systems Inc Earnings Call

  • What does CAS Medical Systems Inc’s (NASDAQ:CASM) Balance Sheet Tell Us About Its Future?
    Simply Wall St.5 months ago

    What does CAS Medical Systems Inc’s (NASDAQ:CASM) Balance Sheet Tell Us About Its Future?

    CAS Medical Systems Inc (NASDAQ:CASM) is a small-cap stock with a market capitalization of US$31.44M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies,Read More...

  • CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017
    Capital Cube7 months ago

    CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017

    Categories: Yahoo FinanceGet free summary analysis CAS Medical Systems, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of CAS Medical Systems, Inc. – NeuroMetrix, Inc., Utah Medical Products, Inc., Royal Philips NV Sponsored ADR, Masimo Corporation and General Electric Company (NURO-US, UTMD-US, PHG-US, MASI-US and ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of CASM earnings conference call or presentation 9-Nov-17 3:00pm GMT

    Q3 2017 CAS Medical Systems Inc Earnings Call

  • Zacks Small Cap Research8 months ago

    CASM: Operational Successes Bode Well For Restarting Sensors Sales Growth

    U.S. FORE-SIGHT sales not only returned to growth (+2% yoy and +5% qoq) in Q3, but at $3.8M, set a new record high.  But, with tissue oximetry sales falling by almost 9% yoy and roughly flat sequentially, it was far from a strong quarter as it relates to financial results.  The lack of top-line growth has recently been impacted by softness in China (as that country awaits CFDA approval of FORE-SIGHT ELITE) but remains largely tied to absence of traction in sensor sales, which account for more than 90% of tissue oximetry revenue.  As we have indicated in previous updates, the lack of sensor-related revenue growth in the face of an ever-larger monitor installed base is somewhat anomalistic, in our opinion. As it relates to the sales force, turnover has meant average tenure (and related productivity) decreased – but on the (more recent) positive side, management indicated that overall productivity has improved and sensor-related revenue growth among the more tenured reps has been relatively very strong (which could be a harbinger of maturation-correlated productivity gains among the less tenured).

  • Capital Cube8 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : November 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Should Your Next Investment In The Healthcare Industry Be In CAS Medical Systems Inc (CASM)?
    Simply Wall St.8 months ago

    Should Your Next Investment In The Healthcare Industry Be In CAS Medical Systems Inc (CASM)?

    CAS Medical Systems Inc (NASDAQ:CASM), a USD$20.77M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population andRead More...

  • How Financially Strong Is CAS Medical Systems Inc (CASM)?
    Simply Wall St.8 months ago

    How Financially Strong Is CAS Medical Systems Inc (CASM)?

    While small-cap stocks, such as CAS Medical Systems Inc (NASDAQ:CASM) with its market cap of USD $20.77M, are popular for their explosive growth, investors should also be aware of theirRead More...

  • Capital Cube9 months ago

    ETFs with exposure to CAS Medical Systems, Inc. : October 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CAS Medical Systems, Inc. Here are 5 ETFs with the largest exposure to CASM-US. Comparing the performance and risk of CAS Medical Systems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)